Industries
Drugs / Biologics
Medical & Surgical
Food
SOX Compliance
IT Control and PCI
Customer Support
Call: 800-447-9407
Fax: 302-288-6884
support@globalcompliancepanel.com
News
...more news
Packs
Featured Speakers
Teri C. Soli
Principal Consultant, Soli Pharma Solutions

Vincent M. Dailey
Executive Vice President, Quality Assurance Systems, Inc.

Charles H Pierce
Consultant, Clinical Research / Drug-Device Development,
Live Webinars
37 webinars found.

Key Modules of an Effective CAPA SOP
This webinar will examine the stated intent of the Agency to get tougher across the board in its expectations for the medical industry and its compliance to the cGMPs, especially CAPA.
Live  Wednesday, September 8, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00

Effective & Essential CAPA process to avoid FDA 483
How do you prevent becoming another FDA statistic? Poor corrective and preventive action (CA/PA) and investigations continue to be among top FDA Form 483 deficiencies issued to drug, biologic, and medical device manufacturers.
Live  Wednesday, September 8, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00

Verification of Pharmacopeia Methods
Laboratories that work in a GMP environment are required to have documentation to show they are qualified to run specific, consistent and reliable analytical test methods.
Live  Thursday, September 9, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:90 Minutes
$245.00

Signal Detection and Data Mining in Pharmacovigilance
This webinar will cover the fundamentals of signal detection, and how these can be augmented by the use of data mining techniques.
Live  Thursday, September 9, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:90 Minutes
$245.00

Learning from Recent FDA Warning Letters Related to Computer Validation and Part 11 - Prepare Yourself for the upcoming FDA Part 11 Inspections
On July 8, 2010, the FDA announced to soon conduct a series of inspections related to 21 CFR Part 11.
Live  Thursday, September 9, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:75 Minutes
$245.00

Understanding Acceptance Activities for Medical Devices
Acceptance activities are common in device manufacturing, but seem to cause problems for some manufacturers. These problems range from simple instances of lack of procedures or acceptance criteria to misapplication of statistical methods.
Live  Tuesday, September 14, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:75 Minutes
$245.00

Physical Properties Analytical and Screening Techniques
The chemical composition of the active ingredient of a pharmaceutical dosage form determines the efficacy and stability of the formulation however during manufacturing it is the physical properties of the formulation components that are critical in the unit operations.
Live  Tuesday, September 14, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$165.00

Auditing API Manufacturers and Suppliers
This program will focus on the basics needed to perform an API audit. Performing an audit is not simply an act of visiting a firm and checking off a list of questions.
Live  Tuesday, September 14, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00

Troubleshooting ethylene oxide (EO) processes
Not every parameter in the EO sterilization process in critical for the determination of the SAL. This presentation will outline the various parameters and what actions should be taken when they are not compliant to the process specification.
Live  Wednesday, September 15, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00

Law Enforcement and Pain Management
Class participants will familiarize themselves with the federal laws and regulations enforced by DEA pertaining to Schedules II though V controlled substances that are dispensed, or prescribed by a physician as part of a pain treatment plan.
Live  Thursday, September 16, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:90 + 15 Minutes Q&A
$245.00

FDA Requirements for Device Labeling: Development, Contents, Distribution, and Changes
Marketing wants to entice customers to buy your product instead of your competitor's! A common method is to make the labeling as eye-catching as possible.
Live  Thursday, September 16, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00

Why Medical Device Companies Receive Warning Letters
The Commissioner of the US FDA has stated the agency will be more enforcement oriented and quicker to issue Warning Letters. This presentation will review current enforcement practices of the US FDA with actual Warning Letters recently issued to medical device companies.
Live  Tuesday, September 21, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:90 Minutes
$245.00

Quality by Design (QbD) and Analytical Methods
As the industry is moving towards applying Quality by Design (QbD) to process development, the question must be asked: Is this also the way forward to revolutionise, improve and standardise our approach to method development and qualification?
Live  Tuesday, September 21, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:90 Minutes
$245.00

Auditing Computer System Validation Materials
This presentation will provide auditors who are not knowledgeable about computer system validation with a basic understanding of the requirements and expectations for validation documentation.
Live  Tuesday, September 21, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00

Managing the IDE (Investigational Device Exemption) Submission for Compliance Success
An investigational device exemption (IDE) allows the investigational device to be used in a clinical study in order to collect safety and effectiveness data required to support a Premarket Approval (PMA) application or a Premarket Notification [510(k)] submission to FDA.
Live  Tuesday, September 21, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00

The Cosmetic-Cosmeceutical Distinction: Walking the Line in Developing Label Claims
Drafting claims where you "walk the line" between cosmetic and drug claims is an art with little existing practical guidance.
Live  Wednesday, September 22, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:90 Minutes
$245.00

Design History File, and Technical File / Design Dossier - A Regulatory Overview
This webinar will examine both the FDA and MDD regulatory expectations for the respective DHF and TF / DD.
Live  Wednesday, September 22, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00

Preparing for FDA Inspections in a Changing Regulatory Environment
Ready for Inspection by Hamburg's FDA? Under Commissioner Hamburg's new enforcement policy, FDA has issued more warning letters more quickly than it has in years.
Live  Wednesday, September 22, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00

Developing and Implementing an Effective Product Specification
A good specification not only defines the product and process being purchased by the customer, but also serves as an extension of the purchasing contract.
Live  Thursday, September 23, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$165.00

Environmental and Product Compliance - Sustainability
Many leading organizations have recognized the need to manage environmental risks and demonstrate a commitment to sustainability and related environmental compliance.
Live  Thursday, September 23, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:90 Minutes
$165.00

Outsourced processes and ISO 9001:2008
In 2008, a new edition of ISO 9001 went into effect. The literature says the new version doesn't introduce any new requirements but only clarifications to the existing requirements.
Live  Tuesday, September 28, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:75 Minutes
$245.00

Robust Process Validation for Medical Devices
One of the most common reasons noted by the FDA for recalls of medical device is improper validation.
Live  Tuesday, September 28, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00

Preparing for and Surviving an FDA Inspection
The purpose of the FDA inspection is a verification activity that should demonstrate to the regulatory agency and provide assurance that products consistently meet quality expectations and that your company is operating in a consistent and compliant state of control.
Live  Tuesday, September 28, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00

The FDA Tripod - Clinical Trial Regulations, Compliance and GCP in Drug Development
This course provides a comprehensive review of Good Clinical Practice (GCP) and FDA regulations and requirements.
Live  Wednesday, September 29, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$195.00

Managing Product Medical Device Recall Efficiently and Effectively
Recall means the correction or removal of a device for human use where FDA finds that there is a reasonable probability that the device would cause serious, adverse health consequences or death.
Live  Thursday, September 30, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00

Development, Management, and Operation of an Effective Supplier and Internal Auditing System
The FDA regulations contain a vast quantity of requirements, which govern tasks performed by your company’s personnel every day.
Live  Thursday, September 30, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00

How to Survive a DEA Audit or FIND=FINE
This training entitled "How to Survive a DEA Audi or FIND=FINE" will cover all the record-keeping and security requirements that a DEA registered pharmacy must comply with when handling controlled substances and regulated chemicals.
Live  Thursday, September 30, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:2 Hours
$245.00

Signal Detection and Case Processing: Business Process Optimization in Pharmacovigilance
This course will describe how to assess and optimize pharmacovigilance operations from cost effective, compliance, and safety perspectives.
Live  Tuesday, October 5, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00

Secrets of an Effective CMC Regulatory Strategy for Biopharmaceuticals Part 1 - Cell Banking
Cell banking assures that an adequate supply of equivalent well-characterized cells exist for production over the expected lifetime of the biopharmaceutical.
Live  Thursday, October 7, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00

Defining and Managing Protocol Deviation/Violation/Exception
As the purpose of a clinical trial is to determine safety and effectiveness of a treatment, it is imperative that the rules of the trial be followed exactly.
Live  Thursday, October 7, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$195.00

Introduction to Risk Management
This three hour overview of financial risk management will provide the fundamentals to risk management that all managers need to comprehend.
Live  Tuesday, October 12, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:3 Hours
$395.00

Document Approval, Control, and Distribution: How to Meet FDA QSR and ISO 13485 Requirements in a Cost Effective Manner
Document control can be a time- and paper-consuming process.
Live  Tuesday, October 12, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00

Navigating Pediatric Trials from recruitment to successful on-time completion
Drug companies face many challenges in pediatric clinical research. Pediatric trials come with a high level of complexity and cost.
Live  Tuesday, October 12, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$195.00

Using SLAs to Facilitate Enterprise and IT Governance, Risk Management and Compliance (GRC)
This one-of-kind webinar is intended to provide you with practical guidelines on applying SLA concepts to your organization's GRC program.
Live  Wednesday, October 13, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$165.00

The HITECH Acts Impact on HIPPA
The new requirements of the HITECH Act have a significant impact on the privacy and security of health information.
Live  Thursday, October 14, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$165.00

European Drug Safety and Pharmacovigilance Compliance
This webinar will describe European PV requirements, including compliance with applicable laws, regulations and guidance.
Live  Tuesday, October 19, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00

Revamping the 510(k) Clearance Process-Understanding FDA's Proposals
The FDA has proposed an overhaul of the 510(k) clearance system In its release of reports from two working groups, the FDA's goals are to increase the predictability and transparency of the 510(k) process and enhance FDA scientific decision-making.
Live  Wednesday, October 20, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:90 Minutes
$245.00

<<